Carolyn Cross – Chairman and Chief Executive Officer
Chartered Financial Analyst
MBA – York University; HBA – University of Western Ontario
Ms. Cross was one of the initial founders and financial supporters of Ondine Biomedical Inc. in 1999 and currently serves as the Chairman of the board and Chief Executive Officer the Company. Ms. Cross has over 18 years direct experience working with early stage companies and has 25 years experience with public market securities. Previously, Ms. Cross was responsible for managing pension, pooled, mutual and private client funds as a Vice President with Royal Bank Investment Management Inc., the fund management arm of the Royal Bank of Canada. She currently sits on the boards of a number of companies including Periowave Dental Technologies, Inc., OrGenX Biopharma Corp., and Sinuwave Technologies Corp, and sits on the Advisory Board of the McGill University Dental School. Ms Cross is a member of the Women's Presidents Organization, the International Women's Forum, the Toronto Society of Financial Analysts, the Courthill and Cherie Blair Foundations, and the Association for Professionals In Infection Control and Epidemiology. Ms Cross is the Founder of OrGenX Biopharma Corporation, a WEConnect certified company.